Swiss National Bank’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.69M | Sell |
41,400
-400
| -1% | -$55K | ﹤0.01% | 1216 |
|
2025
Q1 | $7.54M | Sell |
41,800
-600
| -1% | -$108K | 0.01% | 1035 |
|
2024
Q4 | $6.64M | Buy |
42,400
+3,300
| +8% | +$517K | ﹤0.01% | 1148 |
|
2024
Q3 | $7.12M | Buy |
39,100
+2,900
| +8% | +$528K | ﹤0.01% | 1111 |
|
2024
Q2 | $6.65M | Hold |
36,200
| – | – | ﹤0.01% | 1099 |
|
2024
Q1 | $6.44M | Buy |
36,200
+300
| +0.8% | +$53.4K | ﹤0.01% | 1138 |
|
2023
Q4 | $4.45M | Sell |
35,900
-3,500
| -9% | -$434K | ﹤0.01% | 1360 |
|
2023
Q3 | $4.57M | Sell |
39,400
-2,700
| -6% | -$313K | ﹤0.01% | 1330 |
|
2023
Q2 | $4.94M | Buy |
42,100
+3,200
| +8% | +$376K | ﹤0.01% | 1324 |
|
2023
Q1 | $3.11M | Sell |
38,900
-4,500
| -10% | -$360K | ﹤0.01% | 1565 |
|
2022
Q4 | $3.44M | Buy |
43,400
+800
| +2% | +$63.4K | ﹤0.01% | 1544 |
|
2022
Q3 | $2.97M | Buy |
42,600
+1,400
| +3% | +$97.6K | ﹤0.01% | 1601 |
|
2022
Q2 | $2.71M | Hold |
41,200
| – | – | ﹤0.01% | 1705 |
|
2022
Q1 | $2.74M | Buy |
41,200
+2,800
| +7% | +$186K | ﹤0.01% | 1847 |
|
2021
Q4 | $2.69M | Buy |
38,400
+6,600
| +21% | +$462K | ﹤0.01% | 1862 |
|
2021
Q3 | $1.66M | Buy |
31,800
+400
| +1% | +$20.9K | ﹤0.01% | 2166 |
|
2021
Q2 | $2.14M | Buy |
31,400
+2,100
| +7% | +$143K | ﹤0.01% | 2056 |
|
2021
Q1 | $2.26M | Buy |
29,300
+400
| +1% | +$30.8K | ﹤0.01% | 1926 |
|
2020
Q4 | $1.73M | Hold |
28,900
| – | – | ﹤0.01% | 1985 |
|
2020
Q3 | $1.24M | Buy |
28,900
+500
| +2% | +$21.5K | ﹤0.01% | 1968 |
|
2020
Q2 | $1.18M | Buy |
28,400
+6,600
| +30% | +$273K | ﹤0.01% | 2015 |
|
2020
Q1 | $943K | Buy |
21,800
+300
| +1% | +$13K | ﹤0.01% | 1863 |
|
2019
Q4 | $1.19M | Buy |
21,500
+1,000
| +5% | +$55.4K | ﹤0.01% | 2037 |
|
2019
Q3 | $712K | Hold |
20,500
| – | – | ﹤0.01% | 2227 |
|
2019
Q2 | $826K | Buy |
+20,500
| New | +$826K | ﹤0.01% | 2217 |
|